US Stock MarketDetailed Quotes
TCRT Alaunos Therapeutics
- 1.2300
- -0.0100-0.81%
Close Apr 18 16:00 ET
- 1.2100
- -0.0200-1.63%
Post 19:43 ET
19.70MMarket Cap-559P/E (TTM)
1.2800High1.2000Low33.09KVolume1.2509Open1.2400Pre Close40.23KTurnover0.25%Turnover RatioLossP/E (Static)16.01MShares10.470052wk High3.12P/B16.41MFloat Cap0.660052wk Low--Dividend TTM13.34MShs Float3600.0000Historical High--Div YieldTTM6.45%Amplitude0.6600Historical Low1.2150Avg Price1Lot Size
About Alaunos Therapeutics Company
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.
Company Profile
SymbolTCRT
Company NameAlaunos Therapeutics
Listing DateSep 22, 2006
Founded2003
CEOMr. Dale Curtis Hogue, Jr
MarketNASDAQ
Employees1
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressNavy Yard Plaza,1 First Avenue,Parris Building 34, 3rd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02129
Phone1-617-259-1970
Websitehttp://www.ziopharm.com
Company Executives
- Name
- Position
- Salary
- Dale Curtis Hogue, Jr
- Director and Interim Chief Executive Officer
- --
- Raffaele Baffa
- Chief Medical Officer
- 1.51M
- Abhishek K Srivastava
- Vice President, Technical Operations
- --
- Ferdinand Groenewald
- Vice President, Finance
- --
- Dr. Robert J Hofmeister, PhD
- Independent Director
- --
- Holger Weis
- Independent Director
- 168.15K
- Robert W. Postma
- Independent Director
- 158.15K
- Jaime Vieser
- Independent Director
- 157.15K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg